BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6269431)

  • 21. The excretion of chorionic gonadotrophin by women with chorioadenoma and choriocarcinoma.
    HOBSON BM
    J Obstet Gynaecol Br Emp; 1959 Apr; 66(2):282-7. PubMed ID: 13655144
    [No Abstract]   [Full Text] [Related]  

  • 22. [Vesicular mole with slight elimination of HCG in a clinical series from 1964 to the present].
    Cappelli N; Giorgi G; Teti G
    Minerva Ginecol; 1977 Nov; 29(11):802. PubMed ID: 609381
    [No Abstract]   [Full Text] [Related]  

  • 23. [Trophoblastic hyperplasia and placental carcinomas].
    Philippe E
    Rev Fr Gynecol Obstet; 1985 May; 80(6):361-6. PubMed ID: 2992064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHEMOTHERAPY IN WOMEN WITH TROPHOBLASTIC DISEASE: CHORIOCARCINOMA, CHORIOADENOMA DESTRUENS, AND COMPLICATED HYDATIDIFORM MOLE.
    HERTZ R; ROSS GT; LIPSETT MB
    Ann N Y Acad Sci; 1964 Apr; 114():881-5. PubMed ID: 14131933
    [No Abstract]   [Full Text] [Related]  

  • 25. Follow-Up After Molar Pregnancy Evacuation: Feasibility of Using Semi-Quantitative Urine Pregnancy Tests.
    Hoppenot C; Zimmerman L; Arlandson M; Lurain JR; Patel A
    J Reprod Med; 2016; 61(5-6):192-6. PubMed ID: 27424357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
    Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
    Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chorioadenoma destruens].
    MACHADO LV
    An Bras Ginecol; 1961 Dec; 52():287-300. PubMed ID: 14467872
    [No Abstract]   [Full Text] [Related]  

  • 28. 18F-FDG PET/CT Demonstrating Chorioadenoma Destruens After Evacuation of Complete Hydatidiform Mole.
    Sharma P
    Clin Nucl Med; 2017 Oct; 42(10):766-767. PubMed ID: 28759528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and comparison of two forms of human chorionic gonadotropin from hydatidiform moles with low and high immunoreactivity.
    Imamura S; Imamichi S; Yamabe T; Ishiguro M
    Am J Obstet Gynecol; 1985 Jan; 151(1):136-41. PubMed ID: 3966497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hydatidiform mole. Diagnosis and therapy].
    Holzmann K; Jonas R
    Med Klin; 1976 May; 71(20):837-43. PubMed ID: 178989
    [No Abstract]   [Full Text] [Related]  

  • 31. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N
    Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and characterization of urinary choriogonadotropin from patients with hydatidiform mole.
    Choy YM; Lau KM; Lee CY
    J Biol Chem; 1979 Feb; 254(4):1159-63. PubMed ID: 105001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variations of urinary antigens in trophoblastic proliferative disorders.
    Hamashige S; Mishell DR; Arquilla ER
    J Clin Endocrinol Metab; 1966 Jun; 26(6):651-60. PubMed ID: 4287989
    [No Abstract]   [Full Text] [Related]  

  • 34. CHORIOADENOMA DESTRUENS.
    SPADEMAN LC; TUTTLE WM
    Am J Obstet Gynecol; 1964 Feb; 88():549-50. PubMed ID: 14123438
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the development of chorioadenoma destruens after vesicular mole. Hormonal data and clinical aspects].
    CHISCI R
    Riv Ostet Ginecol; 1959 Dec; 14():835-52. PubMed ID: 13809898
    [No Abstract]   [Full Text] [Related]  

  • 36. [Value of chorionic gonadotropin detection in urine samples in the diagnosis of hydatid mole (serologic technic)].
    Wawryk J
    Ginekol Pol; 1976 Sep; 47(9):1011-5. PubMed ID: 992460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fluctuations in the level of chorionic gonadotropin in the process of primary treatment of trophoblastic tumors].
    Semenovskiĭ AV
    Akush Ginekol (Mosk); 1978 Dec; (12):21-4. PubMed ID: 216278
    [No Abstract]   [Full Text] [Related]  

  • 38. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follow-up after hydatidiform mole: studies using radioimmunoassay for urinary human chorionic gonadotrophin (HCG).
    Bagshawe KD; Wilson H; Dublon P; Smith A; Baldwin M; Kardana A
    J Obstet Gynaecol Br Commonw; 1973 May; 80(5):461-8. PubMed ID: 4351453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.